Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Should routine neonatal circumcision be a policy to prevent penile cancer? | Opinion: No.

Tang DH, Spiess PE.

Int Braz J Urol. 2017 Jan-Feb;43(1):10-12. doi: 10.1590/S1677-5538.IBJU.2017.01.04. No abstract available.

3.

Estimation of utility weights for human papilloma virus-related health states according to disease severity.

Ock M, Park JY, Son WS, Lee HJ, Kim SH, Jo MW.

Health Qual Life Outcomes. 2016 Nov 28;14(1):163.

4.

Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.

Rashid S, Labani S, Das BC.

PLoS One. 2016 Nov 18;11(11):e0166713. doi: 10.1371/journal.pone.0166713.

5.

HPV Vaccination: Attitude and Knowledge among German Gynecologists.

Kolben TM, Dannecker C, Baltateanu K, Goess C, Starrach T, Semmlinger A, Ditsch N, Gallwas J, Mahner S, Friese K, Kolben T.

Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1074-1080.

6.

A paper-based immunoassay to determine HPV vaccination status at the point-of-care.

Grant BD, Smith CA, Castle PE, Scheurer ME, Richards-Kortum R.

Vaccine. 2016 Nov 4;34(46):5656-5663. doi: 10.1016/j.vaccine.2016.09.021.

7.

Recent advancements in combination subunit vaccine development.

Tan M, Jiang X.

Hum Vaccin Immunother. 2017 Jan 2;13(1):180-185. doi: 10.1080/21645515.2016.1229719.

PMID:
27649319
8.

Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional study.

Liu F, Deng Q, Zhang C, Pan Y, Liu Y, He Z, Sun M, Liu M, Li J, Li X, Zhang C, Hang D, Ning T, Guo C, Liang Y, Xu R, Zhang L, Cai H, Ke Y.

Sci Rep. 2016 May 23;6:26343. doi: 10.1038/srep26343.

9.

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.

Tjon Pian Gi RE, San Giorgi MR, Pawlita M, Michel A, van Hemel BM, Schuuring EM, van den Heuvel ER, van der Laan BF, Dikkers FG.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3231-6. doi: 10.1007/s00405-016-4085-3.

10.

Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018.

Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klußmann JP, Nast A, Pathirana D, Petry KU, Pfister H, Röllinghof U, Schneede P, Schneider A, Selka E, Singer S, Smola S, Sporbeck B, von Knebel Doeberitz M, Wutzler P.

Geburtshilfe Frauenheilkd. 2014 Mar;74(3):233-241. No abstract available.

11.

Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline.

Min KJ, Kwon SH, Kim S, Kim HJ, Seong SJ, Song YJ, Shin JW, Lee KH, Lim MC, Chung HH, Ju W, Hong JH, Lee JW, Kim JW, Bae DS, Lee JK.

J Gynecol Oncol. 2016 May;27(3):e30. doi: 10.3802/jgo.2016.27.e30. Review.

12.

Progress and prospects for L2-based human papillomavirus vaccines.

Jiang RT, Schellenbacher C, Chackerian B, Roden RB.

Expert Rev Vaccines. 2016 Jul;15(7):853-62. doi: 10.1586/14760584.2016.1157479.

PMID:
26901354
13.

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.

Chesson HW, Markowitz LE, Hariri S, Ekwueme DU, Saraiya M.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1363-72. doi: 10.1080/21645515.2016.1140288.

14.

Developing Michigan Cancer Foundation 7 Cells with Stable Expression of E7 Gene of Human Papillomavirus Type 16.

Ghasemi F, Rostami S, Nabavinia MS, Meshkat Z.

Iran J Pathol. 2016 Winter;11(1):41-6.

15.

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.

Wang X, Xiao X, Zhao M, Liu W, Pang L, Sun X, Cen S, Yang BB, Huang Y, Sheng W, Zeng Y.

BMC Res Notes. 2016 Jan 25;9:42. doi: 10.1186/s13104-015-1780-x.

16.

The clinical development process for a novel preventive vaccine: An overview.

Singh K, Mehta S.

J Postgrad Med. 2016 Jan-Mar;62(1):4-11. doi: 10.4103/0022-3859.173187. Review.

17.

Relationship between hWAPL polymorphisms and cervical cancer susceptibility.

Li L, Jiao GL, Qin S, Xiao Q.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13777-82.

18.

A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1.

Wang H, Yu J, Li L.

Onco Targets Ther. 2015 Oct 23;8:3067-77. doi: 10.2147/OTT.S84888.

19.

HPV vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee.

Sauvageau C, Dufour-Turbis C.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1560-5. doi: 10.1080/21645515.2015.1112474.

20.

Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Marín AC, Gisbert JP, Chaparro M.

World J Gastroenterol. 2015 Oct 28;21(40):11273-81. doi: 10.3748/wjg.v21.i40.11273. Review.

Items per page

Supplemental Content

Support Center